Nebivolol Dosing for Hypertension
For most patients with hypertension, start nebivolol at 5 mg once daily and titrate up to 40 mg daily if needed for blood pressure control, with dose increases at 2-week intervals. 1
Standard Dosing Regimen
- Initial dose: 5 mg once daily (with or without food), as monotherapy or in combination with other antihypertensive agents 1
- Titration schedule: Increase dose at 2-week intervals if further blood pressure reduction is required 1
- Maximum dose: 40 mg once daily 1
- More frequent dosing intervals are unlikely to provide additional benefit 1
Dose Adjustments for Special Populations
Severe Renal Impairment
- Initial dose: 2.5 mg once daily for patients with creatinine clearance <30 mL/min 1
- Titrate slowly as needed 1
- Nebivolol has not been studied in dialysis patients 1
Moderate Hepatic Impairment
- Initial dose: 2.5 mg once daily 1
- Titrate slowly as needed 1
- Not recommended in severe hepatic impairment due to lack of safety data 1
Elderly Patients
- No dose adjustment necessary 1
CYP2D6 Poor Metabolizers
- No dose adjustment required, as clinical effects and safety profiles are similar to extensive metabolizers 1
Clinical Efficacy Evidence
- The 5 mg once daily dose reduces resting diastolic blood pressure as effectively as standard doses of atenolol, metoprolol, lisinopril, and nifedipine 2
- Response rates (achieving diastolic BP ≤90 mmHg or ≥10 mmHg reduction) range from 58-81% after 4-52 weeks of treatment 2
- In long-term studies, 78% of patients responded to nebivolol monotherapy, with 72% of patients maintained on monotherapy alone 3
Combination Therapy
- Nebivolol has additive antihypertensive effects when combined with hydrochlorothiazide 2, 4
- In long-term studies, 24% of patients required addition of a diuretic, with 65% of these combination patients achieving response 3
Dosing Equivalence to Other Beta-Blockers
- Nebivolol 5 mg daily is equivalent to metoprolol 50 mg daily for hypertension management 5
- Maximum dose of nebivolol (10 mg) for heart failure is equivalent to metoprolol succinate 200 mg 5
Safety and Tolerability
- Adverse events are infrequent, transient, and mild to moderate 2
- Most common adverse effects include headache, fatigue, paresthesias, and dizziness 2
- No orthostatic hypotension reported in clinical studies 2
- Overall adverse event incidence decreases over time with continued therapy 3
Important Clinical Considerations
- Beta-blockers are not first-line agents for hypertension unless the patient has ischemic heart disease or heart failure 6
- Nebivolol's unique nitric oxide-mediated vasodilatory properties distinguish it from other beta-blockers 2, 7
- The drug does not significantly influence glucose or plasma lipid metabolism 2
- Avoid abrupt discontinuation, which can lead to rebound hypertension or worsening cardiac symptoms 5